TrialThe Journal of clinical endocrinology and metabolism2010

Matrix metalloproteinase-9 is increased in obese subjects and decreases in response to pioglitazone.

Resat Unal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.